Nuria Barbarroja

4.5k total citations
90 papers, 3.0k citations indexed

About

Nuria Barbarroja is a scholar working on Rheumatology, Immunology and Molecular Biology. According to data from OpenAlex, Nuria Barbarroja has authored 90 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Rheumatology, 38 papers in Immunology and 31 papers in Molecular Biology. Recurrent topics in Nuria Barbarroja's work include Systemic Lupus Erythematosus Research (28 papers), Spondyloarthritis Studies and Treatments (15 papers) and Rheumatoid Arthritis Research and Therapies (14 papers). Nuria Barbarroja is often cited by papers focused on Systemic Lupus Erythematosus Research (28 papers), Spondyloarthritis Studies and Treatments (15 papers) and Rheumatoid Arthritis Research and Therapies (14 papers). Nuria Barbarroja collaborates with scholars based in Spain, United Kingdom and United States. Nuria Barbarroja's co-authors include C. López-Pedrera, Eduardo Collantes‐Estévez, M. Á. Aguirre, C. Pérez‐Sánchez, Francisco Velasco, Patricia Ruiz‐Limón, Antonio Vidal‐Puig, Yolanda Jiménez, Antonio Rodríguez‐Ariza and I. Arias de la Rosa and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Nuria Barbarroja

85 papers receiving 2.9k citations

Peers

Nuria Barbarroja

RHEUM

IMMUN

HEMAT

EPIDE

C. López-Pedrera Spain

Kris Vaddi United States

Nicoletta Ronda Italy

Ramon Bonegio United States

Changli Wei United States

Bin Zhou China

Gunther Zahner Germany

Jer-Yuarn Wu Taiwan

Lija Joseph United States

Remigio Moratti Italy

C. López-Pedrera Spain

Nuria Barbarroja

1.3k ×1.2

RHEUM

1.2k ×1.1

965 ×1.0

IMMUN

732 ×1.3

HEMAT

258 ×0.6

EPIDE

Citations per year, relative to Nuria Barbarroja Nuria Barbarroja (= 1×) peers C. López-Pedrera

Countries citing papers authored by Nuria Barbarroja

Since Specialization

Citations

This map shows the geographic impact of Nuria Barbarroja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nuria Barbarroja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nuria Barbarroja more than expected).

Fields of papers citing papers by Nuria Barbarroja

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nuria Barbarroja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nuria Barbarroja. The network helps show where Nuria Barbarroja may publish in the future.

Co-authorship network of co-authors of Nuria Barbarroja

This figure shows the co-authorship network connecting the top 25 collaborators of Nuria Barbarroja. A scholar is included among the top collaborators of Nuria Barbarroja based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nuria Barbarroja. Nuria Barbarroja is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ladehesa-Pineda, Lourdes, Nuria Barbarroja, Alejandro Escudero‐Contreras, et al.. (2023). Differences between early vs. late-onset of psoriatic arthritis: Data from the RESPONDIA and REGISPONSER registries. Joint Bone Spine. 90(4). 105563–105563. 7 indexed citations

Rosa, I. Arias de la, C. Pérez‐Sánchez, Fernando Leiva‐Cepas, et al.. (2023). Clinical features and immune mechanisms directly linked to the altered liver function in patients with rheumatoid arthritis. European Journal of Internal Medicine. 118. 49–58. 13 indexed citations

López-Pedrera, C., Alejandro Ibáñez‐Costa, M. Luque-Tévar, et al.. (2023). The thrombus proteome in stroke reveals a key role of the innate immune system and new insights associated with its etiology, severity, and prognosis. Journal of Thrombosis and Haemostasis. 21(10). 2894–2907. 7 indexed citations

Ruiz‐Limón, Patricia, Lourdes Ladehesa-Pineda, Clementina López‐Medina, et al.. (2021). Potential Role and Impact of Peripheral Blood Mononuclear Cells in Radiographic Axial Spondyloarthritis-Associated Endothelial Dysfunction. Diagnostics. 11(6). 1037–1037. 3 indexed citations

López-Pedrera, C., José M. Villalba, M. Luque-Tévar, et al.. (2021). Therapeutic Potential and Immunomodulatory Role of Coenzyme Q10 and Its Analogues in Systemic Autoimmune Diseases. Antioxidants. 10(4). 600–600. 22 indexed citations

López‐Medina, Clementina, R. Ortega Castro, Carmen Castro, et al.. (2020). Axial and peripheral spondyloarthritis: does psoriasis influence the clinical expression and disease burden? Data from REGISPONSER registry. Lara D. Veeken. 60(3). 1125–1136. 8 indexed citations

López-Pedrera, C., Nuria Barbarroja, M. Luque-Tévar, et al.. (2020). Effects of Biological Therapies on Molecular Features of Rheumatoid Arthritis. International Journal of Molecular Sciences. 21(23). 9067–9067. 25 indexed citations

Rosa, I. Arias de la, Pilar Font, Alejandro Escudero‐Contreras, et al.. (2020). Complement component 3 as biomarker of disease activity and cardiometabolic risk factor in rheumatoid arthritis and spondyloarthritis. Therapeutic Advances in Chronic Disease. 11. 1754256843–1754256843. 17 indexed citations

Aguirre, M. Á., M. Luque-Tévar, M. C. Ábalos‐Aguilera, et al.. (2020). Characterization of Antiphospholipid Syndrome Atherothrombotic Risk by Unsupervised Integrated Transcriptomic Analyses. Arteriosclerosis Thrombosis and Vascular Biology. 41(2). 865–877. 19 indexed citations

10.

López-Pedrera, C., Nuria Barbarroja, M. Luque-Tévar, et al.. (2020). Role of microRNAs in the Development of Cardiovascular Disease in Systemic Autoimmune Disorders. International Journal of Molecular Sciences. 21(6). 2012–2012. 19 indexed citations

11.

Ladehesa-Pineda, Lourdes, I. Arias de la Rosa, Clementina López‐Medina, et al.. (2020). Assessment of the relationship between estimated cardiovascular risk and structural damage in patients with axial spondyloarthritis. Therapeutic Advances in Musculoskeletal Disease. 12. 1759720X20982837–1759720X20982837. 15 indexed citations

12.

Barbarroja, Nuria, I. Arias de la Rosa, Clementina López‐Medina, et al.. (2019). Cardiovascular risk factors in psoriatic disease: psoriasis versus psoriatic arthritis. Therapeutic Advances in Musculoskeletal Disease. 11. 1759720X19880742–1759720X19880742. 8 indexed citations

13.

Pérez‐Sánchez, C., I. Arias de la Rosa, M. Á. Aguirre, et al.. (2018). Circulating microRNAs as biomarkers of disease and typification of the atherothrombotic status in antiphospholipid syndrome. Haematologica. 103(5). 908–918. 31 indexed citations

14.

Jamin, Christophe, Damiana Álvarez‐Errico, Nuria Barbarroja, et al.. (2016). Multi-center harmonization of flow cytometers in the context of the European “PRECISESADS” project. Autoimmunity Reviews. 15(11). 1038–1045. 26 indexed citations

15.

López-Pedrera, C., M. Á. Aguirre, Patricia Ruiz‐Limón, et al.. (2015). Immunotherapy in antiphospholipid syndrome. International Immunopharmacology. 27(2). 200–208. 19 indexed citations

16.

Pérez‐Sánchez, C., Nuria Barbarroja, Patricia Ruiz‐Limón, et al.. (2014). Gene profiling reveals specific molecular pathways in the pathogenesis of atherosclerosis and cardiovascular disease in antiphospholipid syndrome, systemic lupus erythematosus and antiphospholipid syndrome with lupus. Annals of the Rheumatic Diseases. 74(7). 1441–1449. 75 indexed citations

17.

Ruiz‐Limón, Patricia, Nuria Barbarroja, C. Pérez‐Sánchez, et al.. (2014). Atherosclerosis and cardiovascular disease in systemic lupus erythematosus: effects of in vivo statin treatment. Annals of the Rheumatic Diseases. 74(7). 1450–1458. 46 indexed citations

18.

Barbarroja, Nuria, M. Luque, Laura M. López‐Sánchez, et al.. (2009). Additive effect of PTK787/ZK 222584, a potent inhibitor of VEGFR phosphorylation, with Idarubicin in the treatment of acute myeloid leukemia. Experimental Hematology. 37(6). 679–691. 9 indexed citations

19.

Cuadrado, M J, Paula Buendía, Francisco Velasco, et al.. (2006). Vascular endothelial growth factor expression in monocytes from patients with primary antiphospholipid syndrome. Journal of Thrombosis and Haemostasis. 4(11). 2461–2469. 75 indexed citations

20.

López-Pedrera, C., Nuria Barbarroja, G. Dorado, Emilio Siendones, & Francisco Velasco. (2006). Tissue factor as an effector of angiogenesis and tumor progression in hematological malignancies. Leukemia. 20(8). 1331–1340. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact